General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance of common stock (in shares) at Dec. 31, 2020     30,281,520              
Beginning balance of stockholders' equity at Dec. 31, 2020 $ 16,496   $ 3   $ 135,616   $ (1,562)   $ (117,561)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (896)           (896)      
Share-based compensation 315       315          
Net loss (1,999)               (1,999)  
Ending balance of common stock (in shares) at Mar. 31, 2021     30,281,520              
Ending balance of stockholders' equity at Mar. 31, 2021 6,523   $ 3   128,538   (2,458)   (119,560)  
Beginning balance of common stock (in shares) at Dec. 31, 2020     30,281,520              
Beginning balance of stockholders' equity at Dec. 31, 2020 16,496   $ 3   135,616   (1,562)   (117,561)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (478)                  
Net loss (8,201)                  
Ending balance of common stock (in shares) at Jun. 30, 2021     30,281,520              
Ending balance of stockholders' equity at Jun. 30, 2021 (6,478)   $ 3   121,321   (2,040)   (125,762)  
Beginning balance of common stock (in shares) at Dec. 31, 2020     30,281,520              
Beginning balance of stockholders' equity at Dec. 31, 2020 16,496   $ 3   135,616   (1,562)   (117,561)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (1,733)                  
Net loss $ (12,574)                  
Ending balance of common stock (in shares) at Sep. 30, 2021 71,810,419   71,827,317              
Ending balance of stockholders' equity at Sep. 30, 2021 $ 279,562   $ 7   412,985   (3,295)   (130,135)  
Beginning balance of common stock (in shares) at Dec. 31, 2020     30,281,520              
Beginning balance of stockholders' equity at Dec. 31, 2020 16,496   $ 3   135,616   (1,562)   (117,561)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (1,901)           (1,901)      
Share-based compensation (1,856)       (1,856)          
Net loss $ (24,776)               (24,776)  
Ending balance of common stock (in shares) at Dec. 31, 2021 72,027,743   72,027,743 72,027,743            
Ending balance of stockholders' equity at Dec. 31, 2021 $ 267,522 $ 256,208 $ 7 $ 7 413,315 $ 401,702 (3,463) $ (3,463) (142,337) $ (142,038)
Beginning balance of common stock (in shares) at Mar. 31, 2021     30,281,520              
Beginning balance of stockholders' equity at Mar. 31, 2021 6,523   $ 3   128,538   (2,458)   (119,560)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment 418           418      
Share-based compensation 315       315          
Net loss (6,202)               (6,202)  
Ending balance of common stock (in shares) at Jun. 30, 2021     30,281,520              
Ending balance of stockholders' equity at Jun. 30, 2021 (6,478)   $ 3   121,321   (2,040)   (125,762)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (1,255)           (1,255)      
Share-based compensation (3,519)       (3,519)          
Net loss $ (4,373)               (4,373)  
Ending balance of common stock (in shares) at Sep. 30, 2021 71,810,419   71,827,317              
Ending balance of stockholders' equity at Sep. 30, 2021 $ 279,562   $ 7   412,985   (3,295)   (130,135)  
Beginning balance of common stock (in shares) at Dec. 31, 2021 72,027,743   72,027,743 72,027,743            
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 267,522 256,208 $ 7 $ 7 413,315 401,702 (3,463) (3,463) (142,337) (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (123)           (123)      
Share-based compensation 2,050       2,050          
Common stock issued pursuant to acquisition (in shares)     4,212,246              
Common stock issued pursuant to acquisition 23,295   $ 1   23,294          
Net loss (11,572)               (11,572)  
Ending balance of common stock (in shares) at Mar. 31, 2022     76,239,989              
Ending balance of stockholders' equity at Mar. 31, 2022 $ 269,858   $ 8   427,046   (3,586)   (153,610)  
Beginning balance of common stock (in shares) at Dec. 31, 2021 72,027,743   72,027,743 72,027,743            
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 267,522 256,208 $ 7 $ 7 413,315 401,702 (3,463) (3,463) (142,337) (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (2,496)                  
Net loss (22,362)                  
Ending balance of common stock (in shares) at Jun. 30, 2022     76,239,989              
Ending balance of stockholders' equity at Jun. 30, 2022 $ 259,196   $ 8   429,547   (5,959)   (164,400)  
Beginning balance of common stock (in shares) at Dec. 31, 2021 72,027,743   72,027,743 72,027,743            
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 267,522 256,208 $ 7 $ 7 413,315 401,702 (3,463) (3,463) (142,337) (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (4,711)                  
Net loss (36,639)                  
Ending balance of common stock (in shares) at Sep. 30, 2022     76,292,241              
Ending balance of stockholders' equity at Sep. 30, 2022 $ 245,723   $ 8   432,566   (8,174)   (178,677)  
Beginning balance of common stock (in shares) at Dec. 31, 2021 72,027,743   72,027,743 72,027,743            
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 267,522 $ 256,208 $ 7 $ 7 413,315 $ 401,702 (3,463) $ (3,463) (142,337) $ (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (2,927)           (2,927)      
Share-based compensation 10,296       10,296          
Common stock issued pursuant to acquisition (in shares)     4,212,246              
Common stock issued pursuant to acquisition 23,295   $ 1   23,294          
Net loss $ (106,200)               (106,200)  
Ending balance of common stock (in shares) at Dec. 31, 2022 76,292,241   76,292,241              
Ending balance of stockholders' equity at Dec. 31, 2022 $ 180,672   $ 8   435,292   (6,390)   (248,238)  
Beginning balance of common stock (in shares) at Mar. 31, 2022     76,239,989              
Beginning balance of stockholders' equity at Mar. 31, 2022 269,858   $ 8   427,046   (3,586)   (153,610)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (2,373)           (2,373)      
Share-based compensation 2,501       2,501          
Net loss (10,790)               (10,790)  
Ending balance of common stock (in shares) at Jun. 30, 2022     76,239,989              
Ending balance of stockholders' equity at Jun. 30, 2022 259,196   $ 8   429,547   (5,959)   (164,400)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment (2,215)           (2,215)      
Share-based compensation 3,019       3,019          
Net loss (14,277)               (14,277)  
Ending balance of common stock (in shares) at Sep. 30, 2022     76,292,241              
Ending balance of stockholders' equity at Sep. 30, 2022 $ 245,723   $ 8   432,566   (8,174)   (178,677)  
Beginning balance of common stock (in shares) at Dec. 31, 2022 76,292,241   76,292,241              
Beginning balance of stockholders' equity at Dec. 31, 2022 $ 180,672   $ 8   435,292   (6,390)   (248,238)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustment 128           128      
Share-based compensation 2,570       2,570          
Vesting of restricted stock units (in shares)     395,067              
Shares withheld related to net share settlement (in shares)     (134,713)              
Shares withheld related to net share settlement (185)       (185)          
Net loss $ (18,490)               (18,490)  
Ending balance of common stock (in shares) at Mar. 31, 2023 76,552,595   76,552,595              
Ending balance of stockholders' equity at Mar. 31, 2023 $ 164,695   $ 8   $ 437,677   $ (6,262)   $ (266,728)